Nature Search

Diminishing benefits of urban living for children and adolescents’ growth and development

The advantage of living in cities compared with rural areas with respect to height and BMI in children and adolescents has generally become smaller globally from 1990 to 2020, except in sub-Saharan Africa.

Anu Mishra
Bin Zhou
Majid Ezzati
ResearchOpen Access29 Mar 2023
Nature

Volume: 615, P: 874-883
Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway

An important contribution of cancer associated fibroblasts (CAFs) in regulating chemoresistance has been reported. Here the authors investigate the impact of chemotherapy on CAF subsets in patients with high-grade serous ovarian cancer, suggesting that residual ANTXR1+ myofibroblasts are associated with inhibition of anti-tumor immunity.

Monika Licaj
Rana Mhaidly
Fatima Mechta-Grigoriou
ResearchOpen Access12 Feb 2024
Nature Communications

Volume: 15, P: 1-27
Development of a model to predict the age at breast cancer diagnosis in a global population

Ha Young Kim
Jimmy Mullaert
Roman Rouzier
ResearchOpen Access15 Jun 2024
Scientific Reports

Volume: 14, P: 1-8
Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy

S Baulies
L Belin
F Reyal
ResearchOpen Access16 Jun 2015
British Journal of Cancer

Volume: 113, P: 30-36
Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas

Y Delpech
C Coutant
L Pusztai
ResearchOpen Access08 Jan 2013
British Journal of Cancer

Volume: 108, P: 285-291
Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells

M A Matrone
R A Whipple
S S Martin
Research15 Mar 2010
Oncogene

Volume: 29, P: 3217-3227
High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies

M A Bollet
A Savignoni
A Vincent-Salomon
ResearchOpen Access05 Feb 2008
British Journal of Cancer

Volume: 98, P: 734-741
Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2–IIB cervical cancer

E Chéreau
J-G Feron
E Daraï
ResearchOpen Access06 Dec 2011
British Journal of Cancer

Volume: 106, P: 39-44
The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER⁺, HER2⁻ early breast cancer

R Exner
Z Bago-Horvath
P Dubsky
ResearchOpen Access08 Jul 2014
British Journal of Cancer

Volume: 111, P: 837-842
Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary

H Mahdi
R E Swensen
A R Munkarah
ResearchOpen Access19 Jul 2011
British Journal of Cancer

Volume: 105, P: 493-497
Molecular detection of lymph node metastasis in breast cancer patients treated with preoperative systemic chemotherapy: a prospective multicentre trial using the one-step nucleic acid amplification assay

T Osako
H Tsuda
S Nakamura
ResearchOpen Access03 Sept 2013
British Journal of Cancer

Volume: 109, P: 1693-1698
Patients with usual vulvar intraepithelial neoplasia-related vulvar cancer have an increased risk of cervical abnormalities

R P de Bie
H P van de Nieuwenhof
J A de Hullu
ResearchOpen Access09 Jun 2009
British Journal of Cancer

Volume: 101, P: 27-31
Early onset of breast cancer in a group of British black women

R L Bowen
S W Duffy
J L Jones
ResearchOpen Access08 Jan 2008
British Journal of Cancer

Volume: 98, P: 277-281
In vitro and in vivo analysis of B-Myb in basal-like breast cancer

A R Thorner
K A Hoadley
C M Perou
Research01 Dec 2008
Oncogene

Volume: 28, P: 742-751
Are we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based models

E Laas
P Mallon
F Reyal
ResearchOpen Access15 Jan 2015
British Journal of Cancer

Volume: 112, P: 912-917
An external validation study of nomograms designed to predict isolated loco-regional and distant endometrial cancer recurrences: how applicable are they?

S Bendifallah
G Canlorbe
M Ballester
ResearchOpen Access29 Aug 2013
British Journal of Cancer

Volume: 109, P: 1498-1503
The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer

R E Coleman
M C Winter
H Thorpe
ResearchOpen Access16 Mar 2010
British Journal of Cancer

Volume: 102, P: 1099-1105
PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer

G Munkácsy
R Abdul-Ghani
B Györffy
ResearchOpen Access15 Dec 2009
British Journal of Cancer

Volume: 102, P: 361-368
A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profiling

P K Julka
R T Chacko
C M Perou
ResearchOpen Access01 Apr 2008
British Journal of Cancer

Volume: 98, P: 1327-1335
Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype

S E Elsheikh
A R Green
I O Ellis
ResearchOpen Access08 Jul 2008
British Journal of Cancer

Volume: 99, P: 327-334
Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma

C Daveau
S Baulies
F Reyal
ResearchOpen Access08 Apr 2014
British Journal of Cancer

Volume: 110, P: 2195-2200
Accuracy of a nomogram for prediction of lymph-node metastasis detected with conventional histopathology and ultrastaging in endometrial cancer

M Koskas
E Chereau
E Daraï
ResearchOpen Access12 Mar 2013
British Journal of Cancer

Volume: 108, P: 1267-1272
The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy

E Y Tan
M Yan
S B Fox
ResearchOpen Access22 Jan 2009
British Journal of Cancer

Volume: 100, P: 405-411
A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial

E Provenzano
A-L Vallier
H M Earl
ResearchOpen Access08 Jan 2013
British Journal of Cancer

Volume: 108, P: 866-872
Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial

E Alba
J Albanell
A Lluch
ResearchOpen Access23 Jan 2014
British Journal of Cancer

Volume: 110, P: 1139-1147
Ten novel 11q23 chromosomal partner sites

CJ Harrison
A Cuneo
LM Secker-Walker
News29 May 1998
Leukemia

Volume: 12, P: 811-822
Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma

L Rossi
E Laas
F Reyal
ResearchOpen Access17 Sept 2015
British Journal of Cancer

Volume: 113, P: 996-1002
Axillary lymph node micrometastases decrease triple-negative early breast cancer survival

G Houvenaeghel
R Sabatier
E Lambaudie
ResearchOpen Access29 Sept 2016
British Journal of Cancer

Volume: 115, P: 1024-1031

Search

Diminishing benefits of urban living for children and adolescents’ growth and development

Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway

Development of a model to predict the age at breast cancer diagnosis in a global population

Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy

Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas

Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells

High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies

Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2–IIB cervical cancer

The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER⁺, HER2⁻ early breast cancer

Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary

Molecular detection of lymph node metastasis in breast cancer patients treated with preoperative systemic chemotherapy: a prospective multicentre trial using the one-step nucleic acid amplification assay

Patients with usual vulvar intraepithelial neoplasia-related vulvar cancer have an increased risk of cervical abnormalities

Early onset of breast cancer in a group of British black women

In vitro and in vivo analysis of B-Myb in basal-like breast cancer

Are we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based models

An external validation study of nomograms designed to predict isolated loco-regional and distant endometrial cancer recurrences: how applicable are they?

The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer

PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer

A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profiling

Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype

Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma

Accuracy of a nomogram for prediction of lymph-node metastasis detected with conventional histopathology and ultrastaging in endometrial cancer

The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy

A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial

Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial

Ten novel 11q23 chromosomal partner sites

Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma

Axillary lymph node micrometastases decrease triple-negative early breast cancer survival

Search

Quick links

Search

Filter By:

Search

Quick links